Other formats:
BibTeX
LaTeX
RIS
@article{1790617,
author = {Knight, Andrea and Říhová, Lucie and Králová, Romana and Penka, Miroslav and Adam, Zdeněk and Pour, Luděk and Piskáček, Martin and Hajek, Roman},
article_location = {Basel},
article_number = {16},
doi = {http://dx.doi.org/10.3390/jcm10163717},
keywords = {plasmacytoid dendritic cells; MGUS; multiple myeloma; immunosuppressive tumor microenvironment},
language = {eng},
issn = {2077-0383},
journal = {Journal of Clinical Medicine},
title = {Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma},
url = {https://www.mdpi.com/2077-0383/10/16/3717},
volume = {10},
year = {2021}
}
TY - JOUR
ID - 1790617
AU - Knight, Andrea - Říhová, Lucie - Králová, Romana - Penka, Miroslav - Adam, Zdeněk - Pour, Luděk - Piskáček, Martin - Hajek, Roman
PY - 2021
TI - Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma
JF - Journal of Clinical Medicine
VL - 10
IS - 16
SP - 1-11
EP - 1-11
PB - MDPI
SN - 20770383
KW - plasmacytoid dendritic cells
KW - MGUS
KW - multiple myeloma
KW - immunosuppressive tumor microenvironment
UR - https://www.mdpi.com/2077-0383/10/16/3717
N2 - Background: Plasmacytoid dendritic cells (pDCs) play prominent roles in mediating innate and adaptive immune responses. However, it is unclear how pDCs contribute to the immunosuppressive tumor microenvironment described in multiple myeloma (MM). Methods: Newly diagnosed myeloma patients (MM, n = 37) were analyzed to determine the pDC counts in comparison to peripheral blood (PB, n = 53) and bone marrow (BM, n = 10) samples of age-matched healthy donors (HD) using flow cytometry. Second, proliferation of myeloma tumor cells in the presence of freshly isolated pDCs was examined. Third, production of IFN alpha by pDCs co-cultured with MM cells was determined by intracellular staining. Results: We found a highly significant reduction of circulating pDCs (p < 0.0001) and in bone marrow (p < 0.0001) of MM patients compared to HD. We also observed a significant decrease of pDCs (p = 0.004) in BM in patients with monoclonal gammopathy of undetermined significance (MGUS, n = 12). Importantly, we determined that pDCs promote proliferation specifically of MM cells and not the stromal cells and that pDCs secrete IFN alpha upon co-culture with MM tumor cells. Conclusions: Our results show altered pDC frequencies in the BM microenvironment in MGUS and MM patients at diagnosis. We showed the tumor-promoting function of pDCs that may mediate immune deficiencies affecting long-term disease control and treatment outcome.
ER -
KNIGHT, Andrea, Lucie ŘÍHOVÁ, Romana KRÁLOVÁ, Miroslav PENKA, Zdeněk ADAM, Luděk POUR, Martin PISKÁČEK and Roman HAJEK. Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma. \textit{Journal of Clinical Medicine}. Basel: MDPI, 2021, vol.~10, No~16, p.~1-11. ISSN~2077-0383. Available from: https://dx.doi.org/10.3390/jcm10163717.
|
